AEterna Zentaris Inc. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
EUR0.8 |
Market Cap |
EUR41.86 M |
Shares Outstanding |
16.21 M |
Public Float |
- |
AEterna Zentaris Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$0.92 |
Market Cap |
$47.68 M |
Shares Outstanding |
16.21 M |
Public Float |
9.88 M |
Address |
315 Sigma Drive Charleston South Carolina 29486 United States |
Employees | - |
Website | http://www.aezsinc.com |
Updated | 07/08/2019 |
Æterna Zentaris, Inc. operates as a specialty biopharmaceutical company that is engaged in developing and commercializing novel treatments in oncology, endocrinology and women's health. It operates through biopharmaceutical segment. AEterna Zentaris was founded on September 12, 1990 and is headquartered in Charleston, SC. |